GeneNews Ltd Company Profile (TSE:GEN)

About GeneNews Ltd (TSE:GEN)

GeneNews Ltd logoGeneNews Limited is focused on developing and commercializing molecular diagnostic tests for early detection of diseases and for personalized health management, with a primary focus on cancer-related indications. The Company offers Sentinel Principle, which is a platform technology to detect virtually any disease or medical condition from a simple blood sample. The Company also offers ColonSentry, which is a blood-based test for assessing an individual's current risk of having colorectal cancer. The Company operates within the biotechnology, molecular diagnostic and genomic biomarker industry. The Company operates in Canada and the United States, and transacts business primarily with the United States partners and suppliers. The Company's subsidiaries include GeneNews Corporation and GeneNews Inc.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Medical Laboratories & Research
  • Sub-Industry: N/A
  • Symbol: TSE:GEN
  • CUSIP: N/A
  • Web: www.genenews.com/
Capitalization:
  • Market Cap: C$8.7 million
  • Outstanding Shares: 96,663,000
Average Prices:
  • 50 Day Moving Avg: C$0.10
  • 200 Day Moving Avg: C$0.18
  • 52 Week Range: C$0.08 - C$0.53
P/E:
  • Trailing P/E Ratio: N/A
  • P/E Growth: 0.00
Sales & Book Value:
  • Annual Revenue: $701,071.00
  • Price / Sales: 12.41
  • Book Value: C($0.05) per share
  • Price / Book: -1.80
Profitability:
  • EBITDA: ($4,600,000.00)
  • Net Margins: -402.46%
  • Return on Assets: -58.90%
Misc:
  • Average Volume: 273,857 shs.
 

Frequently Asked Questions for GeneNews Ltd (TSE:GEN)

What is GeneNews Ltd's stock symbol?

GeneNews Ltd trades on the Toronto Stock Exchange (TSX) under the ticker symbol "GEN."

How were GeneNews Ltd's earnings last quarter?

GeneNews Ltd (TSE:GEN) announced its quarterly earnings results on Thursday, May, 15th. The company reported ($0.02) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.04) by $0.02. The firm had revenue of $0.20 million for the quarter, compared to analyst estimates of $0.04 million. View GeneNews Ltd's Earnings History.

When will GeneNews Ltd make its next earnings announcement?

GeneNews Ltd is scheduled to release their next quarterly earnings announcement on Friday, November, 10th 2017. View Earnings Estimates for GeneNews Ltd.

Who are some of GeneNews Ltd's key competitors?

Who are GeneNews Ltd's key executives?

GeneNews Ltd's management team includes the folowing people:

  • James R. Howard-Tripp, Executive Chairman of the Board
  • Leslie Auld, Chief Financial Officer, Treasurer, Director
  • Karl Wassmann, Executive Vice President - US Corporate Development
  • Heinrich Dreismann Ph.D., Lead Director
  • Harry A. Glorikian, Independent Director
  • Garth A. C. MacRae, Independent Director
  • Rory B. Riggs, Independent Director

How do I buy GeneNews Ltd stock?

Shares of GeneNews Ltd and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.

What is GeneNews Ltd's stock price today?

One share of GeneNews Ltd stock can currently be purchased for approximately C$0.09.


MarketBeat Community Rating for GeneNews Ltd (TSE GEN)
Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  12 (Vote Outperform)
Underperform Votes:  14 (Vote Underperform)
Total Votes:  26
MarketBeat's community ratings are surveys of what our community members think about GeneNews Ltd and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for GeneNews Ltd (TSE:GEN) (How are Consensus Ratings Calculated?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A
Consensus Price Target History for GeneNews Ltd (TSE:GEN)
Price Target History for GeneNews Ltd (TSE:GEN)
Analysts' Ratings History for GeneNews Ltd (TSE:GEN)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com

Earnings

Earnings History for GeneNews Ltd (TSE:GEN)
Earnings by Quarter for GeneNews Ltd (TSE:GEN)
Earnings History by Quarter for GeneNews Ltd (TSE GEN)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/10/2017        
5/15/2014C($0.04)C($0.02)C$0.04 millionC$0.20 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for GeneNews Ltd (TSE:GEN)
Current Year EPS Consensus Estimate: $-0.38 EPS

Dividends

Dividend History for GeneNews Ltd (TSE:GEN)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for GeneNews Ltd (TSE:GEN)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Headline Trends for GeneNews Ltd (TSE:GEN)
Latest Headlines for GeneNews Ltd (TSE:GEN)
Source:
DateHeadline
marketwatch.com logoGeneNews Announces Q2-2017 Financial Results & Provides Progress Update - MarketWatch
www.marketwatch.com - August 15 at 7:37 PM
finance.yahoo.com logoGeneNews Announces Q2-2017 Financial Results & Provides Progress Update
finance.yahoo.com - August 15 at 7:37 PM
finance.yahoo.com logoGeneNews reports 2Q loss
finance.yahoo.com - August 15 at 7:37 PM
americanbankingnews.com logoGeneNews Ltd. (TSE:GEN) Set to Announce Quarterly Earnings on Tuesday
www.americanbankingnews.com - August 10 at 12:20 PM

Social

Chart

GeneNews Ltd (GEN) Chart for Saturday, October, 21, 2017

This page was last updated on 10/21/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.